PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PSI-352938, A NOVEL NUCLEOTIDE POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY SUBJECTS

被引：0
|
作者：
Symonds, William [1 ]
Denning, Jill M. [1 ]
Albanis, Efsevia [1 ]
Wright, Robert [2 ]
Lai, Alexander [2 ]
Berrey, Michelle [1 ]
机构：
[1] Pharmasset Inc, Princeton, NJ USA
[2] Covance Clin Res Unit Inc, Madison, WI USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1890
引用
收藏
页码：1219A / 1219A
页数：1
相关论文
共 50 条
  • [41] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF THE NOVEL HBV CAPSID ASSEMBLY INHIBITOR ZM-H1505R FOLLOWING MULTIPLE ASCENDING DOSES IN HEALTHY SUBJECTS (PART 2)
    Zhang, Zhijun
    Jiang, Xiuhong
    Hua, Bo
    Liu, Gang
    Xia, Tian
    Deng, Aiyun
    Lu, Hui
    Guo, Ruoling
    Wang, Zhe
    Ren, Ming
    Liang, Bo
    Chen, Huanming
    HEPATOLOGY, 2021, 74 (06) : 1396A - 1396A
  • [42] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF FALDAPREVIR AFTER SINGLE RISING DOSES IN HEALTHY SUBJECTS
    Sennewald, R.
    Narjes, H.
    Yong, C.
    Nehmiz, G.
    Huang, F.
    Stern, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S69 - S69
  • [43] PHARMACOKINETICS, TOLERABILITY AND SAFETY OF ABT-530 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY SUBJECTS.
    Lin, C.
    Dutta, S.
    Clifton, J., II
    Asatryan, A.
    Campbell, A.
    Liu, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S69 - S69
  • [44] Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
    Zhang, Dongmei
    Wang, Zining
    Zhao, Xia
    Lu, Wei
    Gu, Jingkai
    Cui, Yimin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (12) : 1841 - 1848
  • [45] Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects
    Iwamoto, M.
    Wenning, L. A.
    Petry, A. S.
    Laethem, M.
    De Smet, M.
    Kost, J. T.
    Merschman, S. A.
    Strohmaier, K. M.
    Ramael, S.
    Lasseter, K. C.
    Stone, J. A.
    Gottesdiener, K. M.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 293 - 299
  • [46] Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects
    Stass, H
    Dalhoff, A
    Kubitza, D
    Schühly, U
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2060 - 2065
  • [47] Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers
    Liang, Beibei
    Wang, Jin
    Bai, Nan
    Chi, Yulong
    Wang, Rui
    Cai, Yun
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (10): : 1184 - 1190
  • [48] Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects
    Li, Min
    Shi, Aixin
    Pang, Hongxian
    Xue, Wei
    Li, Yang
    Cao, Guoying
    Yan, Bei
    Dong, Fan
    Li, Kexin
    Xiao, Wei
    He, Guorong
    Du, Guanhua
    Hu, Xin
    JOURNAL OF ETHNOPHARMACOLOGY, 2014, 156 : 210 - 215
  • [49] A PHASE 1 STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS (PK) OF SINGLE ASCENDING ORAL DOSES OF THE NS3/4A PROTEASE INHIBITOR ITMN 191 IN HEALTHY SUBJECTS
    Bradford, Williamson Z.
    Rubino, Christopher
    Porter, Steve
    Forrest, Alan
    Blatt, Lawrence M.
    Patat, Alain A.
    HEPATOLOGY, 2008, 48 (04) : 1146A - 1146A
  • [50] Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects
    Bauer, M.
    Zeitlinger, M.
    Todorut, D.
    Boehmdorfer, M.
    Mueller, M.
    Langer, O.
    Jaeger, W.
    PHARMACOLOGY, 2013, 91 (1-2) : 12 - 19
12345